key: cord-0990648-med1vjmj authors: Morecchiato, Fabio; Coppi, Marco; Baccani, Ilaria; Maggini, Niccolò; Ciccone, Nunziata; Antonelli, Alberto; Rossolini, Gian Maria title: Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems date: 2021-09-23 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.09.046 sha: 246bcb0a8e739d5c81606990e25fbbd2cc8850c1 doc_id: 990648 cord_uid: med1vjmj Objective : When using high-throughput batched diagnostic platforms based on RT-PCR for SARS-CoV-2 detection, avoidance of the conventional nucleic acid extraction step can help to reduce the turnaround time and increase processivity. This approach can also spare reagents and plasticware, which have experienced a shortage during the initial waves of the pandemic, reducing the overall testing costs. Methods : This study evaluated the performance of extraction-free protocols based on simple dilution of the specimen in sterile RNAse free water (with or without a heating step) in comparison to standard RNA extraction protocols, using two commercial kits for molecular detection of SARS-CoV-2 (Allplex™ SARS-CoV-2 assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV assay) in nasopharyngeal swabs (NPS). Results : Compared with conventional protocols, extraction-free protocols based on sample dilution without a heating step exhibited a lower analytical sensitivity: 74% and 82% with the Allplex™ SARS-CoV-2 assay (tested with 139 NPS samples) and the Allplex™ SARS-CoV-2/FluA/FluB/RSV assay (tested with 69 NPS samples), with a mean increase of Ct values of +2.04 and +1.32, respectively. Most false negative results were observed with sampled of low viral load. Including a step of heath exposure did not improve but actually decreased the analytical sensitivity of the assay. Conclusions : Results confirmed that extraction-free protocols could be a faster and cheaper approach to SARS-CoV-2 detection in NPS samples, that could improve processivity of diagnostic platforms. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) analysis of nasopharyngeal swabs (NPS) or other respiratory specimens represents the reference method for SARS-CoV-2 infection diagnosis (WHO, 2020) . Analytical platforms which can process large batches of specimens allow high-throughput testing but require relatively long turn-around times (TAT), due to the need for an RNA extraction step followed by PCR set-up and finally thermal cycling. Several studies have recently evaluated the possibility of SARS-CoV-2 RNA detection without a conventional RNA extraction step, to reduce TAT and spare extraction reagents and plasticware, that during the pandemic waves have experienced a serious shortage (Brown et al., 2020; Bruce et al., 2020; Merindol et al., 2020) . In particular, a heating step for inhibitors inactivation and RNA release, performed before rRT-PCR in place of conventional extraction, was proposed as a possible alternative for faster SARS-CoV-2 detection in nasopharyngeal swabs (Barza et al., 2020; Lübke et al., 2020) . The aim of this study was to evaluate the performance of rapid extraction-free protocols using two commercial rRT-PCR assays. The material analysed with extraction-free methods was represented by anonymized residual samples of NPS in UTM® medium (Copan, Italy) submitted to the Microbiology and Virology Unit of Florence Careggi University Hospital (Florence, Italy) for SARS-CoV-2 detection in the period August -November 2020. The samples were selected among those already processed with the corresponding conventional method within 24 hours, and were always stored at 4°C. A first group of 139 samples was evaluated using the Allplex™ SARS-CoV-2 assay (ALLPLEX-COV, Seegene Inc, South Korea) with three different methods: i) RNA extraction with the STARMag 96 X 4 Universal Cartridge Kit (Seegene Inc, South Korea) followed by PCR set-up and cycling (STARMAG protocol); ii) direct PCR set-up after dilution of the sample (1:4) in sterile RNase-free water (EX-FREE protocol); iii) direct PCR set-up after dilution of the sample (1:4) in sterile RNase-free water and heating at 98 °C for 3 minutes (EX-FREE-HEAT protocol). The ALLPLEX-COV assay consists in a multiplex rRT-PCR able to simultaneously detect four viral targets including the envelope (E) gene, the RNA-dependent RNA polymerase (RdRP) gene, the spike (S) gene, the nucleocapsid (N) gene, and an exogenous RNA-based internal control (IC). According to the manufacturer's indications, samples were considered positive when a signal was detected at cycle threshold (Ct) <40 for any target gene, negative if only the IC was amplified, and invalid if the IC was not amplified. The reverse transcriptase reaction was carried out at 50 °C for 20 min, followed by a step at 95 °C for 15 min. The PCR reaction consisted of 45 cycles of 10 s at 95 °C, 15 s at 60 °C and 10 s at 72 °C. A second group of 69 samples was evaluated using the Allplex™ SARS-CoV-2/FluA/FluB/RSV assay (ALLPLEX-COV-FLU) with the STARMAG protocol and the EX-FREE protocol. The ALLPLEX-COV-FLU assay performs a multiplex rRT-PCR able to simultaneously detect three SARS-CoV-2 viral targets, including the E, RdRP and N genes, an exogenous RNA-based IC, and an endogenous DNA-based IC. Samples were considered positive when a signal was detected at Ct <40 for any target gene, negative if only the ICs were amplified, or invalid in the absence of amplification of the endogenous and/or exogenous IC. The reverse transcriptase reaction was carried out at 50 °C for 20 min, followed by a step at 95 °C for 15 min. The PCR reaction consisted of 42 cycles of 10 s at 95 °C, 15 s at 60 °C, and 10 s at 72 °C. All samples were processed using a Hamilton Microlab NIMBUS automated extraction and PCR setup system (Hamilton Company, USA), and rRT-PCR was performed with a CFX96 thermal cycler (BioRad, USA). rRT-PCR results were interpreted with the SARS-CoV-2 viewer software according to manufacturer's instructions. Graphical projections and statistical analysis (p value, r squared) were performed using GraphPad Prism 7.0 (GraphPad Software, Inc., San Diego, CA). Percentages of analytical sensitivity, specificity, positive predictive value and negative predictive value with their 95% confidence intervals (CI) were calculated using the "Jeffreys" method (http://www.ausvet.com.au). Comparison of results obtained with the ALLPLEX-COV assay using conventional extraction vs. two extraction-free protocols Overall, 139 samples were included in this evaluation, including 96 positives and 43 negatives with the standard methodology using the extraction step recommended by the manufacturer (STARMAG protocol), and considered as true positives (TP) and true negatives (TN), respectively. The mean cycle threshold (Ct) values with the TP samples were 30.03, 30.23 and 29.72 for the E, ), respectively. Of the TP, 71/96 (74%) and 55/96 (57%) were positive with the EX-FREE and the EX-FREE-HEAT protocols, respectively, while no TN sample was called positive by the two extraction-free protocols ( Altogether, these results showed that the extraction-free protocols exhibited an overall lower analytical sensitivity than the conventional protocol, and that the EX-FREE protocol exhibited a higher analytical sensitivity than the EX-FREE-HEAT protocol (Table 1 ). In fact, samples called as FN with the EX-FREE protocol always exhibited Ct values >32 with the conventional STARMAG protocol. Comparison of results obtained with the ALLPLEX-COV-FLU assay using extraction vs. an extractionfree protocol Overall, 69 samples were included in this part of the study. Of these, 39 were TP and 30 TN ( Table 1 ). The mean Ct values among the 39 TP were 24.13, 22.92 and 23.53 for S, R and N genes (ranges 12.5-38.6, 12.7-39.2, 13.61-36.34), respectively. Considering the higher analytical sensitivity obtained with ALLPLEX-COV and the EX-FREE protocol, only the latter extraction-free protocol was tested in comparison with the conventional protocol. Of the TP, 32/39 (82%) were positive with the EX-FREE protocol, while no TN sample was called positive by the EX-FREE protocol. These results showed that also with the ALLPLEX-COV-FLU the EX-FREE protocol exhibited an overall lower analytical sensitivity than the STARMAG protocol. Endogenous IC analysis also showed an increase of average Ct values with the EX-FREE protocol (p<0.001) with both positive (+2.84) and negative (+4.06) samples (Figure 3) , that was higher than the Ct value observed with SARS-CoV-2 targets (p<0.05). This might be explained by a higher difficulty to release human cellular material by the EX-FREE protocol. During the initial waves of the COVID-19 pandemic, a rapidly increasing demand for molecular testing has been experienced on a global scale, while diagnostic laboratories have often experienced difficulties to comply with the testing workload due to shortages of reagents, plasticware, diagnostic platforms and manpower (Barra et al., 2021) . Under these circumstances, the possibility to shorten the analytical workflow by skipping the conventional nucleic acid extraction step, when using high-throughput RT-PCR diagnostic platforms that rely upon separate steps of RNA extraction, PCR set-up and amplification, appeared an appealing alternative to reduce the TAT which could also spare reagents and plasticware (Smyrlaki et al., 2020) . Nowadays, the shortage of diagnostics for SARS-CoV-2 detection is no longer a major issue in high-income countries, but it remains an issue in medium-and low-income countries. Moreover, extraction-free methods allow TAT and cost reduction which are of interest for all settings and may be helpful for detection of other viral pathogens. Results obtained in this study revealed that a simple dilution step of the UTM matrix used for NPS in sterile RNAse-free water could be successfully used in place of the conventional RNA extraction step with two different commercial rRT-PCR assays. As expected, skipping the conventional nucleic acid extraction protocol (which also results in some concentration of the sample) was associated with some reduction of the analytical sensitivity of the test. However, the reduction was overall moderate, especially with the simplest protocol which did not include a heating step. In fact, the EX-FREE method showed a higher analytical sensitivity and a better concordance with the STARMAG protocol than the EX-FREE-HEAT protocol, when using the ALLPLEX-COV kit. The relatively large amount of false negatives with positive samples yielding high Ct values in the conventional test revealed a loss of accuracy for extraction-free protocols with samples with a low viral load. However, these cases are known to exhibit lower infectivity (Singanayagam et al., 2020) and are often typical of the late stages of infection, when diagnosis has already been made. To the best of our knowledge, this is the first study where ALLPLEX-COV and ALLPLEX-COV-FLU assays used with conventional and extraction-free protocols were compared. Previous studies (Ambrosi et al., 2021; Freppel et al., 2020) were carried out with Allplex™ 2019-nCoV assay (Seegene Inc.), which was available before the former systems and did not target the S gene nor included an endogenous DNA-based IC. Previous studies revealed that a thermal lysis step (90 °C for 3 min) of 1:5 diluted samples slightly improved the efficiency of SARS-CoV-2 detection (Freppel et al., 2020) . Comparable results were obtained with a longer heating step (65 °C for 20 min), but without sample dilution and with a different rRT-PCR protocol (Barza et al., 2020) . Different samples dilution ratio and heating steps could explain at least in part the variability observed between previous and our data. A limitation of this study was that, since ALLPLEX-COV and ALLPLEX-COV-FLU were provided at different times, it was impossible to make a comparison between the two systems with the same set of samples. The feasibility of extraction-free SARS-CoV-2 RNA detection protocols was evaluated with two highthroughput rRT-PCT assays. Results revealed that, despite some reduction of analytical sensitivity, these protocols could be an acceptable method for SARS-CoV-2 detection in clinical samples in case of shortage of the extraction reagents. Moreover, the use of these extraction-free protocols, which are cheaper and faster than the conventional protocols using a nucleic acid extraction step, could reduce testing costs and increase processivity of the analytical platforms. SARS-CoV-2: Comparative analysis of different RNA extraction methods Overcoming supply shortage for SARS-CoV-2 detection by RT-qPCR Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection Validation of an extraction-free RT-PCR protocol for detection of SARS-CoV-2 RNA Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step Efficient SARS-CoV-2 detection in unextracted oronasopharyngeal specimens by rRT-PCR with the Seegene Allplex TM 2019-nCoV assay Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials SARS-CoV-2 detection by direct rRT-PCR without RNA extraction Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19 Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR WHO: World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance Authors would like to thank Arrow Diagnostics S.r.L. (Italy) for kindly providing the assay kits used in this study.